Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2
作者
H.A. Burris,J.D. Hainesworth,Kathy S. Albain,Michael O. Huntington,Francesco Greco,Joan B. Erland,A. Hussain,C. L. Vogel